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Tumor suppression in mice lacking GABARAP,
an Atg8/LC3 family member implicated in autophagy,
is associated with alterations in cytokine secretion and
cell death
FS Salah1,2, M Ebbinghaus3, VY Muley4,5, Z Zhou6, KRD Al-Saadi2, M Pacyna-Gengelbach7, GA O'Sullivan8, H Betz8,9, R König4,5,
Z-Q Wang6,10, R Bräuer1 and I Petersen*,1
GABARAP belongs to an evolutionary highly conserved gene family that has a fundamental role in autophagy. There is ample
evidence for a crosstalk between autophagy and apoptosis as well as the immune response. However, the molecular details for
these interactions are not fully characterized. Here, we report that the ablation of murine GABARAP, a member of the Atg8/LC3
family that is central to autophagosome formation, suppresses the incidence of tumor formation mediated by the carcinogen
DMBA and results in an enhancement of the immune response through increased secretion of IL-1β, IL-6, IL-2 and IFN-γ from
stimulated macrophages and lymphocytes. In contrast, TGF-β1 was significantly reduced in the serum of these knockout mice.
Further, DMBA treatment of these GABARAP knockout mice reduced the cellularity of the spleen and the growth of mammary
glands through the induction of apoptosis. Gene expression profiling of mammary glands revealed significantly elevated levels of
Xaf1, an apoptotic inducer and tumor-suppressor gene, in knockout mice. Furthermore, DMBA treatment triggered the
upregulation of pro-apoptotic (Bid, Apaf1, Bax), cell death (Tnfrsf10b, Ripk1) and cell cycle inhibitor (Cdkn1a, Cdkn2c) genes in the
mammary glands. Finally, tumor growth of B16 melanoma cells after subcutaneous inoculation was inhibited in GABARAP-
deficient mice. Together, these data provide strong evidence for the involvement of GABARAP in tumorigenesis in vivo by delaying
cell death and its associated immune-related response.
Cell Death and Disease (2016) 7, e2205; doi:10.1038/cddis.2016.93; published online 28 April 2016
Gamma (γ)-aminobutyric acid type A receptor (GABAAR)-
associated protein (GABARAP) was first identified as a
trafficking molecule for GABAARs in neurons.
1 We previously
reported that GABARAP may function as a candidate tumor
suppressor in breast cancer. Introduction of the gene into a
breast cancer cell line reduced the growth rate and colony
formation in vitro and suppressed tumorigenicity in nude mice.
In addition, overexpression of the gene was associated with
cytoplasmic vesicle formation,2 a finding supported by the fact
that GABARAP has been shown to be involved in autophagy.3
Specifically, it was shown that GABARAP has a crucial
role in the autophagic process through mediating membrane
hemifusion and to be involved in the maturation of
the autophagosome, a key component of autophagy
machinery.4,5 As autophagy is a fundamental mechanism for
most cells, it is not surprising that the gene is ubiquitously
expressed. Knockout (KO) of the gene, however, did not reveal
an obvious pathological phenotype.6 This might be due to the
fact that GABARAP belongs to a gene family. Its homolog in
yeast, autophagy-related gene 8 (Atg8), is an essential gene
and mutants die under starvation.7 In mammals, there are
several Atg8 homologs grouped into two subfamilies:
microtubule-associated protein-1 light chain 3 (LC3) and
GABARAP, of which LC3 is the most well known as it is
widely used to monitor autophagic activity.8 The fundamental
importance of this gene family in mammals may also be
derived from the fact that Atg8 is an ubiquitin-like protein. Thus
it is possible that the Atg8 gene family may have a similar
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relevance for autophagy as ubiquitin has for proteasomal
protein degradation.9
Autophagy is an intracellular pathway for bulk degradation
of damaged proteins and organelles within the lysosome/
vacuole to recycle building blocks for biosynthesis and cellular
energy under conditions of stress.10 Its role in cancer is
complex and controversial. It may act as a tumor-promoting
as well as tumor-suppressive mechanism depending on the
cellular context and the genetic background.11 In particular,
there is a close relationship between autophagy and apoptosis
and some of the molecular constituents in this interplay have
already been identified. In most cases, autophagy delays or
prevents apoptosis, but in a few circumstances, it may also
assist cell death.12
Apart from apoptosis, autophagy is deeply integrated into
tumor immunity,13 metabolism14 and the stress response.15 In
addition, it has been identified as a potential target of cancer
therapy.16 Interestingly, the disruption of Atgs has been
associated with immunity and inflammation.17 Specifically,
GABARAP KO was shown to increase the secretion of
proinflammatory cytokines in the context of sepsis. KO mice
were highly susceptible to mortality and revealed increased
proinflammatory cytokine secretion through activation of the
NOD-like receptor family, pyrin domain containing 3 inflamma-
some in two sepsis models.18 Tumor-promoting inflammation,
avoiding immune destruction and resisting cell death have
been identified as hallmarks for tumor initiation and
progression.19 It has been proposed that cancer cell-
associated autophagy has a key role in subverting anti-tumor
immunity.20
The aim of our study was to use a GABARAP KO mouse
model to evaluate the potential in vivo role of the gene in
tumorigenesis and to clarify whether it acts as a tumor
suppressor or enhancer. Our data confirm its relevance for
tumor growth with respect to 7,12-dimethylbenz(a)anthracene
(DMBA)-induced tumor development as well as syngenic
tumor cell inoculation. Unlike our previous in vitro data, we find
that GABARAP acts as tumor enhancer in vivo, which seems
to be related to the inhibition of apoptosis and antitumor
immune response.
Results
Reduction of tumor incidence in GABARAP KO mice. In
order to investigate the potential roles of GABARAP in tumor
incidence, female GABARAP KO (KO) and wild-type C57BL/
6J (Wt) mice were treated with DMBA. Tumors arose in 14 of
the 29 Wt mice (48.3%) within 35 weeks after the last dose of
DMBA. In KO mice, tumor formation was significantly reduced
(4 of 33; 12.1%; P=0.002, Table 1). A variety of tumors
developed in each group, for instance, mammary, skin and
liver tumors as well as lymphomas. When only mammary
tumors were considered, a difference between 21.4% (3 out
of the 14 tumors in Wt mice) and 0% (0 of the 4 tumors in KO
mice) was observed (Table 1).
Large tumors (41.5 cm2) were only found in Wt mice,
whereas only small tumors (≤1 cm2) occurred in KO mice
(Figure 1a).
Enhanced sensitivity of GABARAP KO mice to DMBA
induced immunotoxicity. In addition to mutagenicity,
DMBA treatment elicits an immunotoxic effect mainly on
splenic cells.21 In our model, both DMBA-treated groups
reduced the spleen volume; however, KO mice showed a
higher reduction in comparison with Wt mice after DMBA
treatment (Figure 1b). Spleen weights of DMBA-treated Wt
mice were decreased to about 40.5% (±0.7%) of vehicle-
treated Wt mice (Figure 1c). However, a more substantial
decrease was observed in spleen weights of DMBA-treated
KO mice (13.6±1.8%, in comparison with vehicle-treated KO
mice, Figure 1c).
Consistent with spleen weight, a significant decrease in the
total number of splenocytes after DMBA treatment was seen
in KO mice (11.6±2.4% of splenocytes from vehicle-treated
KO mice) compared with Wt mice (44.7± 2.8%, Figure 1d).
Furthermore, fluorescence-activated cell sorting (FACS)
analyses were carried out to detect the alterations in the cell
populations of splenocytes. KO mice showed a substantial
reduction in the number of macrophages, B cells, T cells
(CD8+ and CD4+) and regulatory T cells (Tregs) compared
with Wt mice after DMBA treatment (Supplementary Figures
S1A–E). These results highlight the lack of a selective effect of
DMBA on particular cell types in both KO and Wt mice. To
assess whether the reduction in spleen size and weight was
due to cell death, a terminal deoxynucleotidyl transferase
dUTP nick-end labeling (TUNEL) assay was performed.
TUNEL-stained spleen sections showed increased numbers
of TUNEL-positive cells in the DMBA-treated groups. How-
ever, the number of TUNEL-positive cells was significantly
increased in DMBA-treated KO mice compared with Wt
counterparts (Figures 1e and f).
Cytokine secretion from both macrophages and
lymphocytes are elevated in GABARAP KO mice. Many
autophagic genes are known to have a role in immunity, and
disruption of GABARAP gene has been reported to increase
lethality and expression of interleukin (IL)-1β in two sepsis
mouse models.18 Here we wanted to determine whether
GABARAP deficiency has a role in cytokine secretion
upon DMBA treatment. Lipopolysaccharide (LPS)/LPS+ATP
(adenosine triphosphate)-stimulated macrophages from
DMBA-treated KO mice secreted significantly more IL-1β
and IL-6 than macrophages from Wt counterparts (Figures 2a
and b). No significant differences were seen for tumor
Table 1 Tumor types and incidence in C57BL/6 J wild-type (Wt) and GABARAP
KO (KO) mice after DMBA treatment
Tumor type C57BL/6J (Wt) GABARAP KO (KO)





Undifferentiated tumors 2 1
Total 14 (48.3%) 4 (12.1%)**
**Significant difference between two groups (Po0.01) calculated by Fisher’s
exact test
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necrosis factor alpha (TNFα) secretion between both groups
(Figure 2c).
DMBA-treated mice have been reported to be persistently
immunosuppressed, mainly through suppression of IL-2.22
Surprisingly, in our model anti-CD3-stimulated lymphocytes
from DMBA-treated KO mice produced significantly more IL-2
and interferon (IFN)-γ than stimulated lymphocytes from Wt
counterparts (Figures 2d and e). No difference was seen
for the secretion of IL-17 between both groups of mice
(Figure 2f).
Interestingly, we found that the level of transforming growth
factor beta 1 (TGF)-β1 was significantly reduced in the serum
of DMBA-treated KOmice compared withWt mice (Figure 2g).
This is in line with the suppressive function of TGF-β1
towards T helper 1 cell (TH1)-derived cytokines, such as IL-2
and IFN-γ.23
Cell death in mammary glands is promoted in mice
lacking GABARAP. DMBA is highly carcinogenic when
administered to adult female mice by oral gavage and
especially relevant to study mouse mammary gland tumori-
genesis.24 Therefore, we explored the mammary epithelial
cell growth and ductal tree morphogenesis in our model.
Mammary glands of both female KO and Wt mice at 14 weeks
of age showed normal mammogenesis, and no obvious
phenotypic difference in mammary epithelial cell growth was
noticed (Figure 3a). Furthermore, the mammary glands of Wt
mice treated with DMBA also showed phenotypically
normal mammary epithelial trees compared with vehicle-
treated Wt mice (Figure 3a). However, the mammary glands
of DMBA-treated KO mice showed a massive reduction of
epithelial cell outgrowth and ductal branching compared
with vehicle-treated KO or DMBA-treated Wt mice (Figure 3a).
Figure 1 Impact of GABARAP deficiency on the mice upon DMBA treatment. (a) Size of all the tumors induced by DMBA in Wt and GABARAP KO mice. (b) Representative
picture of the spleens removed fromWt and GABARAP KO mice at the same age (14 weeks) and treatment condition. (c) Spleen weights for vehicle-treated (control) and DMBA-
treated mice (14 weeks). (d) Total number of splenocytes. The data were calculated using three mice per group and shown as means±S.E.M. (e and f), Quantitative analysis and
immunofluorescence TUNEL staining of spleen sections. The data were calculated using 3–6 mice per group and shown as means± S.E.M. Scale bars= 100 μm. *Po0.05,
**Po0.01, ***Po0.001
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Additionally, the lengths of the ductal outgrowths in DMBA-
treated KO mice were significantly shorter than in all other
groups of mice (Figure 3b). Moreover, TUNEL-stained
mammary gland sections of DMBA-treated KO mice showed
a significantly increased number of TUNEL-positive cells
compared with the other groups (Figure 3c). Thus cellular
death is highly elevated when these KO mice are exposed to
the genotoxic carcinogen DMBA. This may explain the
inhibition of tumor formation of mice after DMBA treatment.
Increased expression of tumor-suppressor X-linked
inhibitor of apoptosis protein (Xiap)-associated factor 1
(Xaf1) in GABARAP KO mice. To investigate the potential
cellular and molecular mechanisms by which mammary
tumor development, branching and ductal outgrowth was
suppressed in KO mice by DMBA treatment, microarray
based gene expression profililing of the mammary glands
was performed. The four experimental groups of mice chosen
were: vehicle-treated Wt (CWT), vehicle-treated KO (CKO),
DMBA-treated Wt (DWT), and DMBA-treated KO (DKO).
From this data, a subset of genes whose expression was
altered in a GABARAP-dependent manner between CWT
and DWT was analyzed. The set of the most differentially
expressed genes upon KO is shown in a heat map
(Figure 4a). As expected, there was a pronounced difference
in GABARAP expression between Wt and KO mice. In
addition, the analysis revealed that Xaf1 gene was highly and
differentially expressed in the mammary glands of KO
mice (Figure 4a and Table 2). Xaf1 functions as a tumor
suppressor, and its epigenetic silencing was associated with
cancer development and progression.25–27 We additionally
explored the relationship between GABARAP and Xaf1
expression by interrogating different expression databases.
Interestingly, the levels of GABARAP were significantly higher
when compared to Xaf1 in normal and malignant breast
tissues as well as cancer cell lines from various organs
(Supplementary Figures S2 and S3).
Xaf1 was originally identified as a novel negative regulator
of Xiap.28 Interestingly, in our model Xiap shows a significant
upregulation in Wt mice upon DMBA treatment, whereas
DMBA-treated KOmice exhibited only modest downregulation
of Xiap compared with vehicle-treated KO mice (Table 2).
These findings suggest that Xaf1 upregulation in the
mammary glands of KO mice contributes to the inhibition of
tumor formation and in so doing enhance cell death induction
upon DMBA treatment.
Alteration in gene expression in mammary glands of
DMBA-treated mice. We further analyzed the expression of
genes controlling cell death, cell cycle, DNA replication and
autophagy in the data obtained from our mammary gland
microarray expression experiments. We found numerous
genes that were differentially expressed upon DMBA treat-
ment (Table 2). In DMBA-treated KO mice, pro-apoptotic (Bid,
Apaf1), cell death (Tnfrsf10b, Ripk1) and cell cycle control
(Cdkn2c) genes were upregulated compared with vehicle-
treated KO mice. Bax, Siva1 and Cdkn1a were upregulated
upon DMBA treatment in Wt as well as in KO mice, compared
with their vehicle-treated counterparts. In Wt mice only,
DMBA treatment had a positive effect on the expression of
Cdc7, Cdk1 (genes encoding essential proteins of cell cycle
control), E2f4, Tfdp2 and NF-κB1 (transcription factors). NF-
κB1 had been reported to have a role in mammary
tumorigenesis as an early event, which is induced by DMBA
treatment.24,29 Apart from those genes that were upregulated
only a few genes were downregulated in the mammary
Figure 2 Cytokine secretion is enhanced in GABARAP KO mice. (a) IL-1β, (b) IL-6 and (c) TNFα were measured from the supernatants of LPS- and LPS+ATP-stimulated
peritoneal macrophages after treatment of the mice with DMBA (n= 3 per group). (d) IL-2, (e) IFN-γ and (f) IL-17 were measured in the supernatants of unstimulated and
anti-CD3-stimulated (CD3) splenic lymphocyte after treatment of the mice with DMBA (n= 6–11 per group). (g) TGF-β1 levels in the serum of Wt and GABARAP KO mice that
had been untreated (naive) or treated with DMBA (n= 6/8 per group). Data are representative of triplicate experiments and are shown as means±S.E.M. *Po0.05, **Po0.01,
***Po0.001
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glands of KO mice upon DMBA treatment (Stmn4, Tgfb3,
E2f1). Overexpression of Siva1 had been found to inhibit
stathmin (Stmn), an important regulatory protein of micro-
tubule dynamics, leading to suppression of epithelial–
mesenchymal transition and metastasis.30
Moreover, several autophagy genes were significantly
upregulated in Wt and KO mice after DMBA treatment
(Table 2). To further investigate the effect of DMBA on the
autophagic response in GABARAP Wt and KO cells, we
conducted western blotting analysis in mouse embryonic
fibroblasts (MEFs). As depicted in Supplementary Figure S4,
the conversion of soluble LC3A/B-I to lipid-bound LC3A/B-II is
an indicator of autophagy induction in response to DMBA
treatment. In addition, the upregulation of GABARAP and
degradation of p62 in Wt MEFs indicates proper autophagic
response while the impairment of autophagy in GABARAP-
deficient MEFs is represented by the accumulation of p62
(Supplementary Figure S4).
To verify these results on a subset of genes, we performed
qRT-PCR analysis using the same set of mRNAs that has
been used for the oligo microarray chips. We found that the
relative mRNA expression of Xaf1 was significantly upregu-
lated in mammary glands of vehicle- and DMBA-treated KO
mice in comparison to its Wt counterparts (Figure 4b).
Consistent with the microarray data, we found that the
expression levels of Bax and Cdkn1a were significantly
upregulated in both groups of mice upon DMBA treatment.
However, levels of Bax andCdkn1awere significantly higher in
the treated KO mice compared with their Wt counterparts
(Figures 4c and d).
GABARAP deficiency inhibits growth of inoculated tumor
cells. We also analyzed whether the genetic background of
the recipient may affect the tumor growth of inoculated B16
melanoma cells. All the Wt mice presented palpable tumors
at the ninth day of cell injection compared with 66.7% of
KO mice (Figures 5a and b). The tumor growth increased
constantly in both groups, but the tumor volume was
significantly decreased in KO mice compared with Wt mice
over the whole period of observation (Figure 5b). This result
suggests that intact GABARAP function in the host animal is
advantageous for the growth of the inoculated syngenic
melanoma cells.
Discussion
In this study, we examined the potential role of GABARAP in
tumor formation induced by the chemical carcinogen DMBA.
We demonstrated that the ablation of GABARAP expression
significantly diminished tumor incidence. GABARAP has a
fundamental role in autophagosome formation, a key structure
of the autophagy machinery.5 Contradictory results have been
reported for the roles of specific autophagy genes in
neoplasia. Despite that Beclin1 having been demonstrated
as having a tumor-suppression function for autophagy,31 KO of
Atg5, Atg7 and FIP200, other essential autophagy proteins,
Figure 3 Elevated cell death in the mammary glands of GABARAP KO mice. (a) Whole mount analysis of mammary glands from 14-week-old female Wt and GABARAP KO
mice, which were either vehicle-treated (control) or DMBA-treated. LN, lymph node, N, nipple; scale bars= 5 mm. (b) Mammary epithelial cell growth in the mice as described in
panel (a). The epithelial cell growth was determined by measuring the distance from the lymph node to the end of epithelial tree (in millimeter), using a ruler. Values are
representative of 6–9 mice and are shown as means± S.E.M. (c) Quantification of the number of TUNEL positive cells within mammary gland sections. The data were calculated
using 3–5 mice per group and shown as means± S.E.M. *Po0.05, **Po0.01, ***Po0.001
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failed to initiate malignant tumor development in vivo.32,33
Based on our knowledge, this is the first report providing
in vivo evidence for the involvement of GABARAP in
tumorigenesis.
It has been previously reported that DMBA treatment
resulted in decreased spleen weight and increased spleno-
cyte death in mice.21 In agreement with these results, DMBA-
treatedWt mice showed a reduction in spleen size, weight and
cell number. Importantly, these effects were more pronounced
in KO mice and were accompanied by increased numbers of
TUNEL-positive splenocytes. Thus GABARAP deficiency
promoted cellular death after genotoxic stress by DMBA,
which is consistent with the role of its homolog Atg8 in yeast
and the concept that autophagy blockade may enhance
cellular death under stress conditions.7,12
The immune response has an essential role in delineating
tumor outgrowth and progression. Cytokine secretion can
trigger cell signaling toward antitumor effects and/or cell death.
This cell to cell communication relies on a panel of cytokines
and an accurate assignment of effector cells. We found that
macrophages from DMBA-treated KO mice significantly
boosted the secretion of IL-1β and IL-6 upon stimulation. It
has been reported that DMBA treatment causes oxidative
stress and mitochondrial dysfunction34 and that autophagy
(mitophagy) is required for mitochondrial maintenance.15
Accumulation of damaged mitochondria could activate the
inflammasome and thereby increase proinflammatory cytokine
secretion.17,18 Therefore, we propose that GABARAP defi-
ciency under a genotoxic stress of DMBA may activate the
inflammasome in macrophages by preventing the removal of
damagedmitochondria, which are responsible for the increased
production of proinflammatory cytokines. In addition, IL-1β was
shown to be engaged in different cellular signaling pathways.
Roy et al.35 demonstrated that high concentrations of IL-1β
induced apoptosis, whereas moderate or low levels kept the
same cells normal or stimulated their growth.
It is known that DMBA treatment results in suppression of
the immune response for prolonged periods of time through
Figure 4 Influence of GABARAPablation on the gene expression profile of mammary glands. (a) Heat map of differentially expressed genes in mammary glands of female Wt
and GABARAP KO mice. A comparative analysis of control Wt (CWT) (n= 3) and DMBA-treated Wt (DWT) (n= 6) with their control KO (CKO) (n= 3) and DMBA-treated KO
(DKO) (n= 6) counterparts identified 50 genes that were significantly altered. (b–d) Relative mRNA expression of Xaf1, Bax and Cdkn1a, respectively, in mammary glands of
vehicle-treated (control) and DMBA-treated mice, as measured by quantitative reverse transcriptase PCR (qRT-PCR). Xaf1 expression was mainly influenced by the GABARAP
genotype (b). Mammary glands from KO animals had elevated expression levels of Xaf1, a result that is consistent with the increased amount of apoptosis of these cells displayed.
In contrast, Bax and Cdkn1a expression was not only affected by the genetic background of the animals (KO versus WT) but also by the DMBA treatment (c, d). The relative
expression values of each gene were normalized to GAPDH for each sample. Values are mean±S.E.M. of 4–6 samples of each group. *Po0.05, **Po0.01, ***Po0.001
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inhibition of lymphocyte activity, mainly by suppressing IL-2
production. Thus DMBA stimulates tumorigenesis via two
mechanisms. First, by inducing DNA mutations, and second,
by downregulating the immune response that is relevant for
cancer cell outgrowth after tumor initiation.22 The response in
GABARAP KO mice seems to be different. Lymphocytes of
DMBA-treated KO mice produced significantly higher levels of
IL-2 and IFN-γ. These results indicated that an immune
enhancement of GABARAP-deficient immunocytes by DMBA
treatment had occurred. Several reports have shown the
efficacy of IL-2 and IFN-γ in antitumor immunity by promoting
innate and adaptive immune responses.36,37 De Palma et al.38
and Wei et al.33 showed effective inhibition of PyMT-driven
tumor growth and metastasis through upregulation of IFN
target genes. Furthermore, Atg5 knockdown in human
melanoma cells enhanced IL-6 production and proliferation
of anti-tumorigenic CD8+IFN-γ+ and CD4+IFN-γ+ T cells.39
To obtain a better insight into themechanism underlying IL-2
and IFN-γ elevation, we analyzed TGF-β1 secretion in the
serum. TGF-β1 was significantly reduced in DMBA-treated KO
mice. Tregs have the ability to produce TGF-β.23 Our FACS
analyses showed that there was a substantial reduction of
Tregs in the spleen of DMBA-treated KO mice, which could be
responsible for TGF-β1 depression. Thus our findings are
consistent with previous observations demonstrating that
TGF-β has a suppressive function towards TH1 cells,
23
suggesting that this is the reason for the enhancement of
IL-2 and IFN-γ production. Altogether, our results revealed that
the KO of GABARAP has a considerable impact on the
immunity of mice through enhancing the secretion of
regulatory cytokines upon carcinogen treatment.
Our results demonstrated that mammary tumors were less
frequent in KO mice after DMBA treatment. This was
accompanied by a highly significant reduction of mammary
epithelial growth. Moreover, the gene expression profile
revealed significant upregulation of several cell death genes.
Xaf1 was found to be differentially expressed in the mammary
glands of KO mice, irrespective of whether these mice were
treated with DMBA or not. This gene has been extensively
studied in the past decade and has been characterized as an
apoptosis-inducer and tumor-suppressor gene. Extremely low
or undetectable Xaf1 expression is a frequent event in several
cancer cell lines,25 as well as in human cancer tissues.26,27
The restoration of Xaf1 expression induced cancer cell
Table 2 List of differentially expressed genes in mammary glands of Wt and KO mice









GABARAP Gamma-aminobutyric acid receptor-
associated protein
− 4.05a 0.2 0.09 −4.16a Autophagy
Xaf1 XIAP-associated factor 1 3.25a 0.22 0.36 3.39a Apoptosis
Xiap X-linked inhibitor of apoptosis 0.51 0.86a 0.05 −0.31 Apoptosis
Bid BH3 interacting domain death agonist 0.16 0.53 0.76a 0.39 Apoptosis
Apaf1 Apoptotic peptidase activating factor 1 − 0.33 0.08 0.59a 0.18 Apoptosis
Bax BCL2-associated X protein 0.03 1.79a 2.03a 0.27 Apoptosis
Tnfrsf10b Tumor necrosis factor receptor super-
family, member 10b
− 0.02 0.62 0.89a 0.25 Cell death
Ripk1 Receptor (TNFRSF)-interacting serine-
threonine kinase1
0.24 0.29 0.53a 0.48 Cell death
Siva1 Apoptosis-inducing factor 0.08 1.3a 1.79a 0.57 Apoptosis
Stmn4 Stathmin-like 4 − 0.01 − 0.51 −1.14a −0.65 Microtubule
destabilizer
Il1r1 Interleukin 1 receptor, type I − 0.41 0.08 0.95a 0.45 Cytokine receptor
Cdkn1a Cyclin-dependent kinase inhibitor 1A
(P21)
− 0.1 3.08a 3.73a 0.55 Cell cycle control
Cdkn2c Cyclin-dependent kinase inhibitor 2C
(p18)
− 0.16 0.58 0.86a 0.12 Cell cycle control
Rbx1 Ring-box 1 0.17 0.49a 0.3 −0.02 Cell cycle control
Cdc7 Cell division cycle 7 0.29 0.5a 0.23 0.02 Cell cycle control
Cdk1 Cyclin-dependent kinase 1 0.77 1.06a 0.35 0.07 Cell cycle control
Tgfb3 Transforming growth factor, beta 3 − 0.19 − 0.51 −0.86a −0.55 DNA replication
NF-κB1 Nuclear factor of kappa light polypep-
tide gene enhancer in B-cell 1
0.34 0.71a 0.6 0.23 Transcription factor
Smad2 SMAD family member 2 0.42 0.67a 0.38 0.13 Transcription factor
E2f1 E2F transcription factor 1 − 0.22 − 0.9a −0.62a 0.07 Transcription factor
E2f4 E2F transcription factor 4 0.71 1.24a 0.76 0.23 Transcription factor
Tfdp2 Transcription factor Dp 2 0.17 0.68a 0.47 −0.04 Transcription factor
GABARAPL2 GABARAP-like 2 0.09 0.65a 0.62a 0.06 Autophagy
Atg12 Autophagy-related 12 − 0.02 0.53a 0.62a 0.07 Autophagy
Prkaa1 Protein kinase, AMP-activated, alpha 1
catalytic subunit
0.2 0.79a 0.7a 0.11 Autophagy
Atg3 Autophagy-related 3 0.1 0.79a 1.08a 0.4 Autophagy
Atg4b Autophagy-related 4B, cysteine
peptidase
− 0.57 − 0.65a −0.15 −0.07 Autophagy
Atg5 Autophagy-related 5 0.33 0.5a 0.28 0.11 Autophagy
Abbreviations: CKO, control (vehicle-treated) GABARAP KO (n= 3); CWT, control (vehicle-treated) wild-type (n= 3); DKO, DMBA-treated GABARAP KO (n= 6);
DWT, DMBA-treated wild-type (n= 6). The values in table represent the logarithmic fold change for each gene
aSignificant expression difference between two groups (P≤0.05) calculated by moderated t-statistic
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apoptosis, cell cycle arrest and inhibited tumor growth in
various types of cancers, as well as resulting in an increased
cell sensitivity to drug-induced apoptosis. 26,27,40
Xaf1 was originally identified as a binding partner and a
novel negative regulator of apoptosis-inhibitor protein, Xiap
thereby acting itself as an apoptosis inducer.28 Xiap functions
through its binding to TNF receptor-associated factors and
caspase family and, thereby, inhibits apoptosis.28 We found
that Xiap was significantly upregulated in the mammary
glands of Wt mice upon DMBA treatment, whereas the
mammary glands of DMBA-treated KO mice exhibited a
modest downregulation. Xaf1 has been reported to induce cell
death through multiple mechanisms. Straszewski-Chavez
et al.41 showed that Xaf1 re-localized to mitochondria in
response to TNF-related apoptosis-inducing ligand and
promoted translocation of Bax into mitochondria and cyto-
chrome C release and thereby induced apoptosis. Consistent
with these observations, our results revealed an enhancement
of the pro-apoptotic genes Bid, Apaf1 and Bax, which are
involved in the intrinsic activation of apoptosis by mitochon-
drial outer membrane permeabilization.12,42 Activation of the
mitochondrial apoptotic pathway by Xaf1 was associated with
dramatically enhanced TNFα expression.42 We did not detect
any difference in TNFα expression in stimulated macro-
phages. However, we found that Tnfrsf10b and Ripk1, both
being TNF receptors, were significantly upregulated in the
mammary glands of DMBA-treated KO mice, suggesting that
the TNFα signaling pathway may have been affected.
Our results have elucidated that autophagy genes are
upregulated after DMBA treatment. Indeed, cell exposure to
genotoxic carcinogens trigger several cellular processes to
bypass the damage induced by such chemicals. Autophagy is
one of these processes that is stimulated in order to cope
under times of stress.15 As autophagy is dependent on
GABARAP, its deficiency may weaken the maintenance of
tissue homeostasis leading to increased incidence of cell
death. The interplay between autophagy and apoptosis has
only partially been defined to date.12 The differential
Figure 5 Inhibition of B16 melanoma cells growth in GABARAP KO mice and a working model to explain these results. (a) Still pictures taken from sacrificed Wt and
GABARAP KO mice at the seventeenth day after the inoculation of 2.5 × 105 B16 melanoma cells. Scale bars= 10 mm. (b) Growth curve of B16 melanoma cells in Wt and KO
mice. Values are representative of 12 mice and are shown as means±S.E.M. **Po0.01, ***Po0.001. (c) Working model summarizing the potential mechanisms of tumor
suppression by GABARAP. The subjection of GABARAP KOmice to a genotoxic stress (DMBA) leads to the over and differential expression of the tumor-suppressor gene Xaf1 in
non-immune cells, an effect that may trigger cell death events underlying the inhibition of tumor formation. GABARAP-deficient immune cells produce elevated levels of several
cytokines under genotoxic stress, which could suppress tumor formation and/or may trigger cell death. Similar mechanisms in the derangement of immune signaling may be
involved in growth suppression seen in the GABARAP KO tumor graft model. This prediction requires further investigation in order to clarify the role of GABARAP removal in the
reduction of inoculated tumor cell growth
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expression of GABARAP and Xaf1 may suggest that these
genes constitute part of a molecular switch in the decision of a
cell to undergo autophagy or apoptosis. The nature of how this
switch in gene expression operates remains a mystery.
Interestingly, Xaf1 has been recognized as an IFN-
stimulated gene and its expression has been promoted by
both IFN and TNFα.43 IFN-induced Xaf1 expression occurs
either through its interaction with the IFN regulatory factor
1-(IRF-1) binding element (IRF-E) or demethylation of CpG
sites within the Xaf1 promoter.44,45 The influence of IFN on
Xaf1 has been shown to occur through the JAK-STAT and JNK
pathways in a transcription dependent manner through the
recruitment of IRF-1.45 Recently, Qiu et al.46 demonstrated an
IRF-1-enhanced Xaf1 gene dependent activation within
glomerular mesangial cells of a rat nephritis model. Therefore,
Xaf1 might represent a mediator for apoptosis that is induced
by cytokines.45 Based on our findings, we propose that
cytokines are involved in the enhancement of Xaf1 expres-
sion, thus pointing to an indirect mechanism of Xaf1 regulation
upon GABARAP removal.
Finally, our results provide evidence for the role of
autophagy in anti-tumor immunity, as we showed that B16
melanoma cells' growth in GABARAP KO mice is reduced.
Further evidence for this link comes fromwork done byNoman
et al.,47 who inoculated Beclin1 knockdown B16 melanoma
cells in a syngenic allograft tumor mouse model. In line with
our results, a decrease in tumor formation was observed and
the autophagy dysfunction was linked to the dysregulation
of antigen-specific T-cell lysis.47 To our knowledge, our
investigation represents the first study that investigated the
role of tumor cell growth by inoculating syngenic tumor cells into
autophagy-deficient mice. As the GABARAP-deficient immune
cells displayed an alteration in cytokine secretion that was able
to boost the anti-tumor immune response, we would like to
propose that this effect may have influenced the growth of the
B16 melanoma cells by similar mechanisms that had been
proposed by Noman et al.,47 that is, anti-tumor immunity. At
least, a cell autonomous interplay between autophagy and
apoptosis mediated by GABARAP could not explain this effect
by itself. The precise role of tumor growth reduction needs to be
clarified through further studies. For example, the role of
microenvironment factors that represent an essential demand
for tumor growth in vivo, needs to be investigated.
In summary, we have identified a novel role of GABARAP in
tumorigenesis by using amousemodel and show that ablation
of GABARAP in vivo inhibits tumor initiation and progression
through enhancement of both antitumor immunity and
cell death signaling, as summarized in a working model
(Figure 5c). The challenge for future investigations will be to
explore the molecular mechanisms of GABARAP in the
regulation of gene expression and immunomodulation upon
cellular genotoxic insult.
Materials and Methods
Mice and DMBA treatment. Wt C57BL/6J mice were purchased from
Charles River (Sulzfeld, Germany). GABARAP KO mice were established from a
colony initially maintained at the Max Planck Institute for Brain Research (Frankfurt,
Germany). The strain background of the GABARAP-deficient mice is the C57BL/6J
strain. As previously reported, GABARAP KO mice were phenotypically
indistinguishable from Wt mice and showed no detectable changes in gross
anatomy.6 DMBA (Sigma-Aldrich, Taufkirchen, Germany) was dissolved in sesame
oil (5 mg/ml). Mice at 6–8 weeks of age received 6 weekly doses of 1 mg DMBA/
mouse by oral gavage. Vehicle-treated (control) groups received just sesame oil.
The mice were monitored weekly for palpable tumor formation. Tumor specimens
were fixed and then stained with hematoxylin and eosin. All animal experiments
were approved by the local government commission for animal protection (No. 02-
018/08 and 02-007/13).
TUNEL assay. Tissue sections were deparaffinized, transferred to antigen
retrieval buffer, heated in a microwave until boiling and kept at sub-boiling
temperature for 10 min. After cooling, sections were washed with PBS and reacted
with terminal deoxynucleotidyl transferase mixture (Fermentas, St. Leon-Rot,
Germany) according to the manufacturer’s instructions. Subsequently, after washing,
sections were incubated with Streptavidin-Cy3 (Sigma-Aldrich) for 2 h. Then
sections were washed again and mounted with coverslips and a DAPI-containing
mounting medium (ProLong Gold, Life Technologies, Darmstadt, Germany). Tissue
section images were acquired using a microscope (Virtual microscope BX61VS,
Olympus, Tokyo, Japan).
FACS analysis. For the analysis of cell surface markers, single-cell
suspensions from the spleens were prepared 1 week after the last dose of DMBA.
Cells were permeabilized by 0.5% (w/v) saponin in PBS (containing 0.25% (w/v)
bovine serum albumin and 0.02% (w/v) sodium azide). Splenocytes (macrophages,
B cells, CD4+ T cells and CD8+ T cells) were analyzed by staining with an antibody
solution containing anti-CD11b-Alexa Fluor 700, anti-B220-Pacific Blue, anti-CD4-
Dye647 and anti-CD8-PE/Cy7 (all obtained from eBioscience, Frankfurt, Germany).
Tregs were analyzed by staining with anti-CD4-APC/Cy7 and anti-CD25-Dye647
and subsequent incubation with FoxP3 Fixation/Permeabilization working solution
(all obtained from eBioscience). Then cells were stained with anti-FoxP3-FITC
(eBioscience). All samples were measured using the flow cytometer BD LSR II
(BD Biosciences, San Jose, CA, USA).
Cytokine analysis. Cytokines were quantified in single-cell suspensions from
the spleens and peritoneal macrophage cultures prepared 1 week after the last
dose of DMBA. As there is almost no basal release of cytokines under in vitro
conditions, lymphocytes (2.5 × 105 cells/ml) were cultured in RPMI medium
(Biochrom, Berlin, Germany) containing 10% (v/v) FCS (Biochrom) for 48 h with
1 μg/ml plate-bound anti-CD3e antibodies (eBioscience) for overall T-cell receptor
stimulation. Macrophages (1.5x105 cells/ml) were stimulated with 1 μg/ml LPS
(Sigma-Aldrich) (4 h) and 5 mM ATP (InvivoGen, Toulouse, France) (1 h) in RPMI
medium containing 10% (v/v) FCS. Cytokines were measured in the supernatants
using standard sandwich ELISA procedures as previously described.48 Primary and
biotin-labeled secondary antibodies for IL-1β, IL-6, TNFα, IL-2 and IFNγ were
purchased from BD Biosciences (Heidelberg, Germany) and antibodies for IL-17
from R&D Systems (Wiesbaden, Germany). For quantification, recombinant
cytokines were used as standard. Absorbance was measured at 492 nm.
TGF-β1 was determined at the same time in the serum using an ELISA Kit
(R&D Systems) according to the manufacturer's instructions.
Whole-mount analysis of the mammary glands. The fourth abdominal
mammary gland was dissected from the pelt and spread on a glass slide and then
submerged into a mixture of absolute ethanol: glacial acetic acid, 3 : 1 (v/v) for 3 h.
Subsequently, the glands were washed with 70% (v/v) ethanol and rinsed in distilled
water. The glands were stained with aluminium carmine (Fluka, Bassersdorf,
Switzerland) overnight. Then the slides were rinsed with 70, 90 and 100% (v/v)
ethanol and transferred to xylene for clearing and mounted with aqueous mounting
medium (Permount, Fisher Scientific, Pittsburgh, PA, USA). Analysis of mammary
epithelial growth was performed by measuring the distance from the lymph node to
the end of epithelial tree using a ruler, according to de Assis et al.49
Microarray gene expression profile. Abdominal mammary glands were
isolated and directly fixed in 5% (w/v) neutral-buffered formalin and subsequently
paraffin blocks were constructed. Microarray workflow was carried out by Miltenyi
Biotec GmbH (Bergisch Gladbach, Germany), using the Agilent Whole Mouse
Genome oligo microarrays 8 × 60K chips (Agilent Technologies, Santa Clara, CA,
USA) according to standard protocols of formalin-fixed paraffin-embedded (FFPE)
samples. Briefly, RNA isolation was performed using the Absolutely RNA FFPE Kit
(Stratagene, Agilent Technologies, Santa Clara, CA, USA) and cDNA was obtained
using the Complete TransPlex Whole Transcriptome Amplification Kit WTA2 (Sigma,
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St. Louis, MO, USA). DNA samples were labeled using the Genomic DNA ULS
Labeling Kit (Agilent Technologies) to produce Cy3-labeled DNA. The hybridization
procedure was performed overnight according to the Agilent Gene Expression
FFPE Workflow protocol using the Agilent Gene Expression Hybridization Kit and
Agilent CGHblock. Fluorescence signals were detected and processed using
Agilent’s Microarray Scanner System and Feature Extraction Software (Agilent
Technologies). Microarray image files were processed using Limma package for the
R language.50 Background correction was performed and arrays were normalized
using loess method. The probes were selected based on having expression intensities
that were above background at least in three samples. Expression levels were
averaged for genes having more than one probe set. Raw P-values for differential
gene expression were derived from moderated t-statistic50 and subsequently corrected
using the Benjamin and Hochberg approach.51 The gene expression differences with
P-values ≤ 0.05 were considered as differentially expressed.
Real-time RT-PCR analysis. The same sets of RNA that were used in
microarray analysis were used for reverse transcription. Total RNA was reverse
transcribed into cDNA using a QuantiTect Reverse Transcription Kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions. Real-time RT-PCR was
performed on the Rotor-Gene 6000 system (Qiagen) using FastStart Universal
SYBR Green Master (Roche, Mannheim, Germany). Twenty-five nanograms of RNA
were used for PCR amplification with the following primer pairs for Xaf1: 5′-TCCAA
GTGTGCAGGAACTG-3′ (forward), 5′-CAACTTCCATGTGCTCTTTCATC-3′ (reverse),
Bax: 5′-TTGGAGATGAACTGGACAGC-3′ (forward), 5′-CAGTTGAAGTTGCCATCAG
C-3′ (reverse), Cdkn1a: 5′-AGGCCCAGTACTTCCTCTGC-3′ (forward), 5′-CAATCTGC
GCTTGGAGTGATA-3′ (reverse), and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH): 5′-CACACCGACCTTCACCATTTT-3′ (forward), 5′-GAGACAGCCGCAT
CTTCTTGT-3′ (reverse). The relative expression value of each gene was
normalized to GAPDH for each sample.
Tumor inoculation. The murine B16 melanoma cell line was kindly provided
by the Institute of Pathology, Charité Hospital (Berlin, Germany). Cells were cultured
in RPMI 1640 medium (Biochrom) supplemented with 10% (v/v) FCS (Biochrom).
For subcutaneous inoculation into the left flank (100 μl), the cells were adjusted to a
concentration of 2.5 × 106 cells/ml in ice-cold PBS. After 1 week, the area where the
inoculated cells had been injected were monitored daily for tumor growth. Tumor
volume was measured every other day using a caliper.
Statistical analysis. Data are expressed as mean±S.D./S.E.M. as indicated.
The significance of tumor incidence between Wt and GABARAP KO mice was
calculated using a Fisher’s exact test. In the other experiments, differences between
groups were calculated using the two-tailed Student’s t-test for unpaired values. The
normal distribution of the values was checked using the Kolmogorov–Smirnov test.
Statistical significance was calculated by the SPSS software package (v.16.0,
SPSS, Chicago, IL, USA), P-values o0.05 were considered as being significant.
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